Velinda Hille

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway

P. Vickerman, Ewa Wilk, K. A. Johansson, 2019, Substance Abuse Treatment, Prevention, and Policy.

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway

A. Lim, P. Vickerman, Ewa Wilk, 2020, Substance Abuse Treatment, Prevention, and Policy.

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020

A. Lim, P. Vickerman, Ewa Wilk, 2020, Substance Abuse Treatment, Prevention, and Policy.

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)

P. Vickerman, Ewa Wilk, E. Løberg, 2019, BMC Infectious Diseases.

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway

A. Lim, P. Vickerman, Ewa Wilk, 2020, Substance Abuse Treatment, Prevention, and Policy.